valproic acid has been researched along with palmidrol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Diependaele, G; Govaerts, SJ; Lambert, DM; Robert, AR; Vandevoorde, S | 1 |
Bertolino, B; Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Impellizzeri, D; Siracusa, R | 1 |
3 other study(ies) available for valproic acid and palmidrol
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
Topics: Amides; Animals; Anticonvulsants; Cannabinoid Receptor Modulators; Cannabinoids; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Endocannabinoids; Ethanolamines; Male; Mice; N-Methylaspartate; Palmitic Acids; Propionates; Seizures; Valproic Acid | 2001 |
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.
Topics: Amides; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Autistic Disorder; Brain; Child; Chymases; Cytokines; Disease Models, Animal; Doublecortin Domain Proteins; Enzyme Inhibitors; Ethanolamines; Follow-Up Studies; Humans; Luteolin; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Neuropeptides; Nitric Oxide Synthase Type II; Palmitic Acids; Tryptases; Valproic Acid | 2017 |